An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease.
Publication: J Neurol
Underwood BR, Green-Thompson ZW, Pugh PJ, Lazic SE, Mason SL4, Griffin J, Jones PS, Rowe JB, Rubinsztein DC7,4, Barker RA.
26 October 2017